Full name
EUROFINS DERMSCAN POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
46 - Wholesale trade
47 - Retail trade
63 - Services related to computing infrastructure, data processing, website management (hosting), and other information services
70 - Head office activities and management consultancy
72 - Scientific research and development activities
73 - Advertising, market research and public relations
74 - Other professional, scientific and technical activities
82 - Office administrative support activities and other business support services
86.9 - Other healthcare activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,9 | -0,3 | -1,4 | -331,6 |
EBITDA | 2,3 | 0,3 | -0,1 | -129,8 |
Short time liabilities | 1,8 | 2 | 4 | 101,1 |
Equity capital | 3,5 | 3,1 | 0,5 | -84,4 |
Operating profit (EBIT) | 2 | -0,1 | -0,7 | -365,4 |
Assets | 8,5 | 8,9 | 10,9 | 23,5 |
Net profit (loss) | 1,5 | -0,4 | -1,1 | -186 |
Cash | 0,7 | 0,5 | 1,3 | 154,1 |
Liabilities and provisions for liabilities | 5 | 5,7 | 10,4 | 83 |
Net income from sale | 22,8 | 23,7 | 24,9 | 5,3 |
Working assets | 6,3 | 6 | 8 | 33,1 |
Depreciation | 0,3 | 0,4 | 0,6 | 33,4 |
% | % | % | p.p. | |
Profitability of capital | 42,9 | -12,6 | -230,9 | -218,3 |
Equity capital to total assets | 41,7 | 35,6 | 4,5 | -31,1 |
Gross profit margin | 8,2 | -1,3 | -5,4 | -4,1 |
EBITDA Margin | 10,2 | 1,3 | -0,4 | -1,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 29 | 30 | 58 | 28 |
Current financial liquidity indicator | 2.3766067028045654 | 2.4274330139160156 | 1.6688939332962036 | -0,7 |
Net dept to EBITDA | 0.3675410747528076 | 3.5071258544921875 | -47.42136764526367 | -50,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane